Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Medstar Health Research Institute
Study ID
NCT07228377
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • virtual reality pain therapy — BEHAVIORAL
    DISCOVR virtual reality pain therapy

Study Details

Patients living with cancer commonly have chronic pain due to the disease or to cancer treatments. Virtual reality, a new technology that immerses the user in pleasant, diverting, and exciting virtual environments, may lower chronic cancer pain to improve quality of life and complement need for pain medications like opioids. The investigators aim to learn from patients about the experience of cancer pain, develop a virtual reality prototype specific to cancer pain management, and test the feasibility and acceptability of this technology to improve the cancer pain experience.

Key Dates

Start date
Dec 1, 2025
Status verified
Nov 2025
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Virtual reality pain therapy

Primary Outcome Measure

Intervention feasibility [ Time Frame: From enrollment to end of treatment at 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MedStar Georgetown Cancer Institute at MedStar Washington Hospital CenterWashington D.C.District of Columbia20010
Eloisa Leiva
[email protected]
(202) 877-5468

Find similar trials in Washington D.C., DC

By research site
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center· Washington D.C., DC

Related Studies